🔎 Trials Near Me

Inicio › Cáncer de pulmón › Misuri

Ensayos clínicos de Cáncer de pulmón en Misuri

44 estudios sobre Cáncer de pulmón buscan participantes en Misuri.

Ciudades en Misuri

Texto oficial del estudio (inglés)

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  • Washington University School of Medicine, St Louis
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Saint Luke's Hospital of Kansas City, Kansas City
  • Saint Luke's East Hospital, Lee's Summit
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • University Health Truman Medical Center, Kansas City
  • Mercy Hospital South, St Louis
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Saint Francis Medical Center, Cape Girardeau
  • Saint Luke's Hospital, Chesterfield
  • y 18 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Saint Francis Medical Center, Cape Girardeau
  • Kansas City Veterans Affairs Medical Center, Kansas City
  • Lake Regional Hospital, Osage Beach
  • y 2 más
ReclutandoFase 3
Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Washington University School of Medicine, St Louis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07020221

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Mercy South - David M Sindelar Cancer Center ( Site 0098), St Louis
  • Mercy Research - David C. Pratt Cancer Center ( Site 0006), St Louis
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06312137

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Saint Luke's Hospital of Kansas City, Kansas City
  • CoxHealth South Hospital, Springfield
  • Washington University School of Medicine, St Louis
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Washington University in St. Louis School of Medicine, St Louis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • y 21 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Saint Francis Medical Center, Cape Girardeau
  • Saint Luke's Hospital, Chesterfield
  • Parkland Health Center - Farmington, Farmington
  • y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Oncology Hematology Associates, Springfield
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  • Missouri Cancer Associates, Columbia
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06712316

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

  • Research Site, St Louis
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06835569

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Washington University, School of Medicine, St Louis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06172478

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Washington University School of Medicine, St Louis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07154290

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • Washington University School of Medicine, St Louis
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

  • Saint Francis Medical Center, Cape Girardeau
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07393555

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Washington University, St Louis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT05786924

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • y 8 más
ReclutandoFase 2
18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • y 15 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • St. Lukes Hospital of Kansas City, Kansas City
  • Washington University School of Medicine, St Louis
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06625775

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Washington University Center for Advanced Medicine, St Louis
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, St Louis
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07127874

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • Local Institution - 0140, St Louis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT06618287

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

  • Siteman Cancer Center Washington University, St Louis
Reclutando
Edades de 21 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07824583

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • University of Kansas Cancer Center - North, Kansas City
  • y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Saint Francis Medical Center, Cape Girardeau
  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
  • Parkland Health Center - Farmington, Farmington
  • y 11 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

  • Barnes-Jewish Christian Hospital, St Louis
ReclutandoSe aceptan voluntarios sanos
Edades de 20 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT07146568

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

  • Barnes-Jewish Hospital West County, Creve Coeur
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT06898333

IDOV-Immune for Advanced Solid Tumors

  • Washington University School of Medicine, St Louis
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06910657

Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

  • University of Missouri - Ellis Fischel Cancer Center, Columbia
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 jul 2026 · NCT06410300

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • Washington University School of Medicine (Siteman Cancer Center), St Louis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jul 2026 · NCT05652686

CARE Tool Study Aim 3

  • Delbert Day Cancer Institute at Phelps Health, Rolla
  • Washington University School of Medicine, St Louis
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 jul 2026 · NCT07296887

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • y 3 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Washington University, St Louis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06051695

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Saint Francis Medical Center, Cape Girardeau
  • Parkland Health Center - Farmington, Farmington
  • University Health Truman Medical Center, Kansas City
  • y 9 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Washington University Infusion Center Pharmacy, St Louis
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 27 may 2026 · NCT03093116

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

  • Washington University School of Medicine, St Louis
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 feb 2026 · NCT04354064

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.